Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan L Davis

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Neurology|October 22, 2013
Fibroblast growth factor 21 is a sensitive biomarker of mitochondrial diseaseRyan L Davis, Christina Liang, Fabienne Edema-Hildebrand, et al.
Frontiers in Neuroscience|September 25, 2020
Mitochondrial Function in Hereditary Spastic Paraplegia: Deficits in <i>SPG7</i> but Not <i>SPAST</i> Patient-Derived Stem CellsGautam Wali, Kishore Raj Kumar, Erandhi Liyanage, et al.
Neurology. Clinical Practice|March 20, 2020
Serum FGF-21, GDF-15, and blood mtDNA copy number are not biomarkers of Parkinson diseaseRyan L Davis, Siew L Wong, Phillippa J Carling, et al.
Thrombosis and Haemostasis|August 28, 2007
Congenital hypodysfibrinogenaemia (Fibrinogen Des Moines) due to a gamma320Asp deletion at the Ca2+ binding siteStephen O Brennan, Ryan L Davis, Michael W Mosesson, et al.
American Journal of Human Genetics|March 8, 2025
Data-driven insights to inform splice-altering variant assessmentPatricia J Sullivan, Julian M W Quinn, Pamela Ajuyah, et al.
Journal of Neurology|May 2, 2019
Parkinson's disease and the gastrointestinal microbiomeMichal Lubomski, Ai Huey Tan, Shen-Yang Lim, et al.
Journal of Neurology|June 15, 2021
The impact of device-assisted therapies on the gut microbiome in Parkinson's diseaseMichal Lubomski, Xiangnan Xu, Andrew J Holmes, et al.
Haematologica|July 26, 2007
Fibrinogen Columbus: a novel gamma Gly200Val mutation causing hypofibrinogenemia in a family with associated thrombophiliaRyan L Davis, Michael W Mosesson, Bryce A Kerlin, et al.
Frontiers in Aging Neuroscience|June 1, 2022
Nutritional Intake and Gut Microbiome Composition Predict Parkinson's DiseaseMichal Lubomski, Xiangnan Xu, Andrew J Holmes, et al.
Microbiome|March 15, 2023
NEMoE: a nutrition aware regularized mixture of experts model to identify heterogeneous diet-microbiome-host health interactionsXiangnan Xu, Michal Lubomski, Andrew J Holmes, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Neurology|October 22, 2013
Fibroblast growth factor 21 is a sensitive biomarker of mitochondrial diseaseRyan L Davis, Christina Liang, Fabienne Edema-Hildebrand, et al.
Frontiers in Neuroscience|September 25, 2020
Mitochondrial Function in Hereditary Spastic Paraplegia: Deficits in <i>SPG7</i> but Not <i>SPAST</i> Patient-Derived Stem CellsGautam Wali, Kishore Raj Kumar, Erandhi Liyanage, et al.
Neurology. Clinical Practice|March 20, 2020
Serum FGF-21, GDF-15, and blood mtDNA copy number are not biomarkers of Parkinson diseaseRyan L Davis, Siew L Wong, Phillippa J Carling, et al.
Thrombosis and Haemostasis|August 28, 2007
Congenital hypodysfibrinogenaemia (Fibrinogen Des Moines) due to a gamma320Asp deletion at the Ca2+ binding siteStephen O Brennan, Ryan L Davis, Michael W Mosesson, et al.
American Journal of Human Genetics|March 8, 2025
Data-driven insights to inform splice-altering variant assessmentPatricia J Sullivan, Julian M W Quinn, Pamela Ajuyah, et al.
Journal of Neurology|May 2, 2019
Parkinson's disease and the gastrointestinal microbiomeMichal Lubomski, Ai Huey Tan, Shen-Yang Lim, et al.
Journal of Neurology|June 15, 2021
The impact of device-assisted therapies on the gut microbiome in Parkinson's diseaseMichal Lubomski, Xiangnan Xu, Andrew J Holmes, et al.
Haematologica|July 26, 2007
Fibrinogen Columbus: a novel gamma Gly200Val mutation causing hypofibrinogenemia in a family with associated thrombophiliaRyan L Davis, Michael W Mosesson, Bryce A Kerlin, et al.
Frontiers in Aging Neuroscience|June 1, 2022
Nutritional Intake and Gut Microbiome Composition Predict Parkinson's DiseaseMichal Lubomski, Xiangnan Xu, Andrew J Holmes, et al.
Microbiome|March 15, 2023
NEMoE: a nutrition aware regularized mixture of experts model to identify heterogeneous diet-microbiome-host health interactionsXiangnan Xu, Michal Lubomski, Andrew J Holmes, et al.
Pageof 7